Comments on: ºÚÁÏ´óÊÂ¼Ç receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases  /bluerock-therapeutics-receives-fda-fast-track-designation-for-opct-001-for-the-treatment-of-primary-photoreceptor-diseases/ Thu, 27 Mar 2025 19:40:40 +0000 hourly 1 https://wordpress.org/?v=6.9.4